Citations

Quantum Blue® Adalimumab: Development of the first point of care rapid test for therapeutic drug monitoring of serum adalimumab levels

Quantum Blue® Infliximab Citation: F. I. Bantleon, S. Kräuchi, T. B. Schuster, M. Schneider, A. P. Abel Read Citation
Read more

The new infliximab point-of-care quantitative test can equally be used for therapeutic drug monitoring of biosimilars of infliximab

Quantum Blue® Infliximab Citation: J. Afonso, H.T. Sousa, I.Rosa, J.Carvalho, C. C. Dias, F. Magro on behalf GEDII Read Citation
Read more

Diagnostic Accuracy of Fecal Calprotectin in Assessing the Severity of Inflammatory Bowel Disease: From Laboratory to Clinic.

BÜHLMANN fCAL® ELISA: S. Moein, D. Quujeq et al. Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic. Caspian J Intern Med 2017; 8(3):178-182 DOI: 10.22088/cjim.8.3.178. Highlights from this Publication “ The current study also suggested 78.4 µg/g as the cut-off level for FC by 100% sensitivity and
Read more

Data-Driven Programmatic Approach to Analysis of Basophil Activation Tests

Flow CAST® ELISA:

Sarita U. Patel. Data-Driven Programmatic Approach to Analysis of Basophil Activation Tests Cytometry B Clin Cytom. 2017 Jun 15. doi: 10.1002/cyto.b.21537. PMID: 28618453.

Read more